Negocios · 25/9/19961 min de lectura
Hance Brothers and White Co., et al.; Withdrawal of Approval of 16 Abbreviated Applications
Traducción automática local · Idioma original de la fuente
Resumen
The Food and Drug Administration (FDA) is withdrawing 3 abbreviated antibiotic applications (AADA'S) and 13 abbreviated new drug applications (ANDA's). The basis for the withdrawals is that the sponsors have repeatedly failed to file required annual reports for these applications.